In the Cruse Lab, our goal is to identify new treatments for mast cell-driven diseases such as allergy, asthma and mastocytosis.
To achieve this, we are conducting research in two main areas:
Through these two avenues, we are elucidating the complex pathways underlying mast cell function and phenotype to identify potential drug targets. Then, by developing novel methods of drug delivery, we are creating new, targeted therapeutics for a variety of mast cell diseases.
Find out more about our ongoing projects in these areas by following the links above.